grass pollen allergen extract: prescribing and clinical use
Focused clinical detail for use alongside current product information, local policy and patient-specific assessment.
grass pollen allergen extract: clinical details
Prescribing considerations
- Confirm clinical relevance and interpret sensitisation in the context of symptoms and exposure history.
- Perform testing only where anaphylaxis treatment and appropriate supervision are available.
- Assess asthma control, cardiovascular disease, beta-blocker use, general health and medicines that may suppress skin reactivity.
- Use healthy, lesion-free skin with appropriate positive and negative controls.
- Infants and older adults may have reduced wheal responses.
Contraindications and cautions
- Hypersensitivity to any excipient in the preparation.
Monitoring
- Confirm valid positive and negative control responses before interpreting the result.
- Observe for local progression, wheeze, angioedema or systemic allergic symptoms.
- Document the wheal response and interpret it alongside clinical history; wheal size does not predict reaction severity.
Clinical pharmacology
Partly purified pollen allergens cross-link grass-specific IgE on cutaneous mast cells, releasing vasoactive mediators and causing an immediate wheal-and-flare response. A delayed local response can also occur. The intended effect is local and diagnostic, not systemic or therapeutic.
Formulation and product differences
- Glycerinated solution containing standardised Timothy grass pollen allergen extract in buffered saline and glycerol.
- Excipients include phosphate buffers, phenol, sodium chloride, glycerol and water for injections.
- Licensed for skin-prick diagnosis and distinct from grass pollen allergen immunotherapy products.
grass pollen allergen extract interactions
Some medicines can suppress the skin response or complicate treatment of a rare severe reaction. Follow the clinic’s instructions and do not stop prescribed medicines without advice.
Antihistamines
May suppress the immediate skin response and cause a false-negative result.
Potent topical corticosteroids on the test area
May suppress the local response and make the result unreliable.
Systemic corticosteroids
Higher or prolonged exposure may reduce skin reactivity, so treatment history must be considered.
Sources
These sources were used to prepare and review this medicine page.
Prepared and reviewed by the iatroX editorial team.